Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

CG Begley, M Ashton, J Baell, M Bettess… - Science Translational …, 2021 - science.org
Drug repurposing is promoted as a cost-and time-effective mechanism for providing new
medicines. Often, however, there is insufficient consideration by academic researchers of …

[HTML][HTML] Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics

Y Gupta, OV Savytskyi, M Coban, A Venugopal… - Molecular Aspects of …, 2023 - Elsevier
With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

S Krasemann, U Haferkamp, S Pfefferle, MS Woo… - Stem cell reports, 2022 - cell.com
Neurological complications are common in COVID-19. Although SARS-CoV-2 has been
detected in patients' brain tissues, its entry routes and resulting consequences are not well …

Comparison of IgA, IgG, and neutralizing antibody responses following immunization with Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and …

T Adjobimey, J Meyer, L Sollberg, M Bawolt… - Frontiers in …, 2022 - frontiersin.org
In an ongoing multinational trial, we obtained blood samples from 365 volunteers vaccinated
with mRNA vaccines (Moderna, BioNTech), viral DNA-vectored vaccines (AstraZeneca …

A machine learning platform to estimate anti-SARS-CoV-2 activities

GB Kc, G Bocci, S Verma, MM Hassan… - Nature Machine …, 2021 - nature.com
Strategies for drug discovery and repositioning are urgently need with respect to COVID-19.
Here we present REDIAL-2020, a suite of computational models for estimating small …

Papaverine: a miraculous alkaloid from opium and its multimedicinal application

S Ashrafi, S Alam, A Sultana, A Raj, NU Emon, FT Richi… - Molecules, 2023 - mdpi.com
The pharmacological actions of benzylisoquinoline alkaloids are quite substantial, and have
recently attracted much attention. One of the principle benzylisoquinoline alkaloids has been …

Different aspects of emetine's capabilities as a highly potent SARS-CoV-2 inhibitor against COVID-19

M Valipour - ACS Pharmacology & Translational Science, 2022 - ACS Publications
In the global movement to find the appropriate agents to fight the coronavirus disease of
2019 (COVID-19), emetine is one of the strongest anti-SARS-CoV-2 compounds with sub …

Dual action anti‐inflammatory/antiviral isoquinoline alkaloids as potent naturally occurring anti‐SARS‐CoV‐2 agents: A combined pharmacological and medicinal …

M Valipour, A Hosseini, A Di Sotto… - Phytotherapy …, 2023 - Wiley Online Library
In the search for compounds that inhibit the SARS‐CoV‐2 after the onset of the COVID‐19
pandemic, isoquinoline‐containing alkaloids have been identified as compounds with high …

Learning from COVID-19: How drug hunters can prepare for the next pandemic

AC Puhl, TR Lane, S Ekins - Drug discovery today, 2023 - Elsevier
Highlights•We provide a brief perspective of our 3 years of COVID-19 research.•We describe
the molecules repurposed with activity against SARS-CoV-2.•The foundational work prior to …

Natural products-based drug design against SARS-CoV-2 Mpro 3CLpro

RC Silva, HF Freitas, JM Campos, NM Kimani… - International Journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has received global attention due to the serious threat it poses …